dc.contributor.author | Lønning, Per Eystein | en_US |
dc.date.accessioned | 2016-03-16T14:24:41Z | |
dc.date.available | 2016-03-16T14:24:41Z | |
dc.date.issued | 2015-07 | |
dc.Published | Steroids 2015, 99:26-31 | eng |
dc.identifier.issn | 0039-128X | |
dc.identifier.uri | https://hdl.handle.net/1956/11693 | |
dc.description.abstract | Plasma estrogen measurement with use of radioimmunoassays has been instrumental in the development of aromatase inhibitors for endocrine therapy of postmenopausal breast cancer. However, due to low plasma estrogen concentrations in postmenopausal women, direct radioimmunoassays lack the sensitivity required. While certain laboratories have developed highly sensitive assays for research purposes revealing plasma estrogen suppression consistent with results from tracer studies, such assays are time and labor-consuming due to need for pre-analytical chromatographic purification, sample concentration and sometimes conversion of precursors to products. While novel chromatographic methods involving mass spectrometry analysis are likely to replace such radioimmunoassays in the future, so far a limited number of laboratories have developed suitable assays with a detection limit (around 1 pM) that is required for analyzing plasma estrogen levels in patients during treatment with potent aromatase inhibitors. | en_US |
dc.language.iso | eng | eng |
dc.publisher | Elsevier | eng |
dc.rights | Attribution CC BY | eng |
dc.rights.uri | http://creativecommons.org/licenses/by/3.0/ | eng |
dc.subject | Estrogens | eng |
dc.subject | Estradiol | eng |
dc.subject | Estrone | eng |
dc.subject | Radioimmunoassay | eng |
dc.subject | Aromatase | eng |
dc.subject | Breast cancer | eng |
dc.title | Estradiol measurement in translational studies of breast cancer | en_US |
dc.type | Peer reviewed | |
dc.type | Journal article | |
dc.date.updated | 2015-10-16T11:50:42Z | |
dc.description.version | publishedVersion | en_US |
dc.rights.holder | Copyright 2014 The Author | |
dc.identifier.doi | https://doi.org/10.1016/j.steroids.2014.08.008 | |
dc.identifier.cristin | 1255117 | |
dc.subject.nsi | VDP::Medisinske fag: 700::Klinisk medisinske fag: 750::Onkologi: 762 | |
dc.subject.nsi | VDP::Midical sciences: 700::Clinical medical sciences: 750::Oncology: 762 | |